Benralizumab
Encyclopedia
Benralizumab is a monoclonal antibody which is being developed by MedImmune
for the treatment of asthma
. It is directed against the alpha-chain of the interleukin-5 receptor
(CD125).
MedImmune
MedImmune, LLC, headquartered in Gaithersburg, Maryland, became a wholly owned subsidiary of AstraZeneca in 2007. Since being acquired, MedImmune has remained a Maryland-based biotechnology development enterprise...
for the treatment of asthma
Asthma
Asthma is the common chronic inflammatory disease of the airways characterized by variable and recurring symptoms, reversible airflow obstruction, and bronchospasm. Symptoms include wheezing, coughing, chest tightness, and shortness of breath...
. It is directed against the alpha-chain of the interleukin-5 receptor
Interleukin-5 receptor
The interleukin-5 receptor is a type I cytokine receptor. It is a heterodimer of the interleukin 5 receptor alpha subunit and CSF2RB....
(CD125).